Victory Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-23,893
Closed -$2.22M 2869
2021
Q4
$2.22M Sell
23,893
-28,778
-55% -$1.9M ﹤0.01% 1525
2021
Q3
$3.14M Buy
52,671
+12,856
+32% +$759K ﹤0.01% 1452
2021
Q2
$2.71M Sell
39,815
-5,638
-12% -$368K ﹤0.01% 1541
2021
Q1
$3.15M Sell
45,453
-507,473
-92% -$39M ﹤0.01% 1502
2020
Q4
$42.5M Sell
552,926
-1,453
-0.3% -$109K 0.05% 573
2020
Q3
$41.5M Sell
554,379
-60,871
-10% -$4.06M 0.05% 522
2020
Q2
$38.7M Sell
615,250
-854,214
-58% -$47M 0.05% 511
2020
Q1
$61.7M Buy
1,469,464
+722,282
+97% +$33.1M 0.05% 502
2019
Q4
$33.9M Buy
747,182
+1,697
+0.2% +$80.2K 0.04% 630
2019
Q3
$34.1M Buy
745,485
+53,415
+8% +$3M 0.04% 592
2019
Q2
$40.6M Buy
692,070
+16,860
+2% +$871K 0.08% 376
2019
Q1
$30.3M Buy
+675,210
New +$31M 0.07% 444

Victory Capital Management's ARNA Position: Q1 2022 in Review

Victory Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 23,893 shares — an estimated $2.22M sold.

Victory Capital Management first reported a position in ARNA in Q1 2019 and held it in 12 quarters. The position peaked at $61.7M in Q1 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Victory Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Victory Capital Management sold 23,893 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.22M.
  • Victory Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 12 quarters.
  • Victory Capital Management's Arena Pharmaceuticals Inc position peaked at $61.7M in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.